extract
echinacea
purpurea
ep
purpl
coneflow
use
tradit
north
america
treatment
variou
type
infect
wound
becom
popular
herbal
medicin
global
recent
studi
reveal
certain
standard
prepar
contain
potent
select
antivir
antimicrobi
activ
addit
display
multipl
immunemodulatori
activ
compris
stimul
certain
immun
function
phagocyt
activ
macrophag
suppress
proinflammatori
respons
epitheli
cell
virus
bacteria
manifest
alter
secret
variou
cytokin
chemokin
immun
modul
result
upregul
downregul
relev
gene
transcript
factor
bioactiv
demonstr
noncytotox
concentr
extract
appear
due
multipl
compon
rather
individu
chemic
compound
character
echinacea
extract
potenti
applic
bioactiv
extract
may
go
beyond
tradit
use
journal
biomedicin
biotechnolog
tabl
tradit
use
echinacea
coneflow
extract
herbal
medicin
deriv
sever
speci
indigen
echinacea
genu
use
throughout
plain
north
america
long
introduct
european
medicin
primarili
treatment
variou
infecti
diseas
wound
nine
discret
speci
classifi
subsequ
botanist
indic
tabl
although
medic
record
suggest
consider
interchang
use
design
speci
occur
consequ
associ
specif
speci
particular
treatment
view
caution
even
recent
year
revis
taxonomi
genu
nevertheless
gener
agre
echinacea
purpurea
purpl
coneflow
wide
use
nativ
peopl
later
eclect
practition
north
america
possibl
widespread
also
appar
effect
number
diseas
current
herbal
prepar
becom
popular
north
america
europ
elsewher
tend
favor
speci
other
major
basic
scientif
studi
focus
one
accordingli
review
restrict
primarili
discuss
e
purpurea
abbrevi
ep
occasion
refer
altern
speci
sourc
materi
scientif
clinic
studi
usual
aqueou
press
juic
ethanol
tinctureextract
aerial
part
dri
plant
root
chemic
composit
differ
substanti
prepar
least
term
known
marker
compound
caffeic
acid
deriv
alkylamid
polysaccharid
claim
contribut
medicin
benefit
howev
uncertainti
ident
princip
bioactiv
compound
made
interpret
basic
clinic
studi
difficult
unfortun
problem
exacerb
frequent
use
uncharacter
sourc
materi
attempt
valid
tradit
use
echinacea
numer
studi
made
recent
effect
character
ep
prepar
virus
bacteria
organ
inflammatori
respons
gene
express
infect
uninfect
human
cell
cultur
well
anim
studi
result
discuss
follow
section
howev
omit
refer
acut
respiratori
infect
human
usual
caus
one
group
wellknown
virus
includ
rhinovirus
common
cold
virus
influenza
virus
b
parainfluenza
virus
corona
virus
respiratori
syncyti
viru
certain
adenovirus
influenza
viru
deserv
special
consider
uniqu
capac
genet
reassort
anim
human
strain
consequ
product
epidem
section
sar
viru
sarshcov
also
merit
addit
comment
explain
section
addit
recent
applic
sensit
molecular
detect
techniqu
reveal
presenc
virus
metapneumovirus
bocavirus
might
also
involv
gener
respiratori
symptom
howev
know
newli
recogn
virus
realli
pathogen
simpli
passeng
elud
previou
diagnost
techniqu
herp
simplex
viru
type
also
produc
oral
mucos
infect
cold
sore
may
accompani
symptom
reminisc
respiratori
virus
clearli
variou
famili
virus
differ
structur
replic
scheme
consequ
bear
differ
potenti
molecular
target
involv
respiratori
symptom
mani
suscept
echinacea
extract
indic
tabl
among
possibl
viral
target
virion
membran
compon
ii
cellular
attach
entri
iii
one
mani
stage
viru
replic
develop
particularli
involv
virusspecif
enzym
iv
egress
progeni
viru
infect
cell
howev
varieti
replic
scheme
among
virus
chanc
success
singl
therapeut
drug
low
especi
consid
major
respiratori
infect
specif
viru
inform
lack
anoth
problem
specif
antivir
target
approach
especi
case
compound
direct
specif
viral
gene
product
inevit
emerg
viru
resist
mutant
subsequ
spread
commun
environ
convent
answer
problem
use
combin
two
antivir
drug
distinct
molecular
target
notwithstand
like
increas
undesir
side
effect
howev
logic
altern
approach
use
noncytotox
agent
capac
inhibit
mani
differ
respiratori
virus
simultan
recent
evid
indic
certain
herbal
extract
could
fulfil
requir
symptom
cold
flu
bronchiti
term
coin
describ
variou
permut
common
symptom
supposedli
brought
action
specif
viral
infect
upper
respiratori
tract
symptom
may
includ
familiar
discomfort
sneez
stuffi
nose
irrit
mucou
membran
excess
mucu
product
sinus
cough
sore
throat
malais
fever
well
exacerb
asthma
copd
chronic
obstruct
pulmonari
diseas
case
symptom
may
spread
includ
lower
respiratori
tract
lung
result
bronchiol
pneumonia
howev
symptom
may
direct
result
viru
replic
mani
case
minim
differenti
airway
tissu
rather
indirect
consequ
virusinduc
inflammatori
respons
respiratori
infect
invad
viru
initi
encount
epitheli
tissu
compos
larg
epitheli
cell
occasion
dendrit
cell
macrophag
cell
respond
mean
variou
antimicrobi
strategi
make
innat
immun
system
includ
defens
peptid
antimicrobi
peptid
secret
variou
proinflammatori
cytokin
mediat
inflamm
molecul
kinin
releas
probabl
respons
earli
symptom
rhinovirus
also
shown
induc
kinin
gene
express
although
effect
like
delay
effect
viru
infect
respons
mediat
phagocyt
cell
variou
type
inflammatori
cell
may
attract
site
infect
addit
redox
balanc
cell
may
advers
affect
either
viru
infect
consequ
proinflammatori
respons
sinc
symptom
reflect
common
nonspecif
host
respons
infect
agent
rather
direct
cytolyt
cytopath
effect
specif
viru
ration
therapeut
approach
would
applic
antiinflammatori
agent
especi
intent
therapi
amelior
symptom
potenti
safe
antiinflammatori
agent
also
contain
multipl
antivir
activ
would
provid
bonu
sever
herbal
extract
shown
possess
combin
bioactiv
could
use
control
respiratori
infect
echinacea
extract
becom
popular
although
variat
chemic
composit
mention
section
necessarili
benefici
influenza
virus
ubiquit
produc
signific
annual
morbid
mortal
throughout
world
potenti
devast
consequ
human
anim
health
global
economi
therear
three
type
influenza
viru
b
c
latter
two
confin
mainli
human
produc
rel
mild
season
outbreak
howev
greatest
impact
deriv
influenza
viru
associ
sever
wellknown
human
pandem
last
centuri
increas
number
epidem
epizoot
domest
bird
believ
influenza
viru
origin
wild
bird
possibl
waterfowl
duck
gees
bird
act
reservoir
vector
mani
known
subtyp
strain
influenza
viru
classic
symptom
human
influenza
includ
cough
malais
fever
often
accompani
sore
throat
nasal
obstruct
sputum
product
resolv
spontan
healthi
individu
although
immun
compromis
elderli
individu
tend
vulner
complic
may
includ
bronchiti
pneumonia
exacerb
asthma
chronic
obstruct
pulmonari
diseas
copd
seriou
diseas
healthi
individu
especi
pandem
often
accompani
excess
overreact
innat
immun
respons
secret
danger
level
cytokin
cytokin
storm
inflammatori
mediat
also
import
concurr
bacteri
infect
overlook
sinc
may
lead
seriou
outcom
thu
ideal
control
agent
abl
prevent
reduc
replic
spread
viru
well
potenti
pathogen
bacteri
infect
also
counteract
overproduct
inflammatori
mediat
vaccin
gener
advoc
routin
applic
influenza
season
outbreak
base
prevail
strain
previou
season
unpredict
natur
influenza
epidem
one
sure
success
vaccin
sever
research
question
wisdom
widespread
vaccin
numer
antivir
drug
use
infect
patient
test
experiment
anim
model
human
none
proven
satisfactori
recent
synthet
compound
neuraminidas
inhibitor
oseltamivir
tamiflu
zanamivir
relenza
drugresist
strain
human
avian
influenza
virus
document
increas
frequenc
earli
studi
show
certain
echinacea
extract
possess
signific
antivir
activ
e
purpurea
ep
aerial
part
root
contain
potent
antivir
activ
virucid
influenza
viru
herp
simplex
viru
coronaviru
distribut
among
one
solvent
deriv
fraction
probabl
reflect
presenc
one
antivir
compound
howev
correl
antivir
activ
composit
recogn
marker
compound
caffeic
acid
polysaccharid
alkylamid
fact
purifi
polysaccharid
fraction
ep
possess
signific
activ
cichor
acid
sever
caffeic
acid
deriv
show
weak
moder
activ
insuffici
account
potent
activ
ep
addit
antivir
activ
commerci
ethanol
tinctur
ep
remain
stabl
least
sever
year
ambient
temperatur
would
seem
rule
mani
potenti
candid
bioactiv
compound
furthermor
antivir
activ
due
photosensit
limit
number
prospect
candid
recent
studi
standard
prepar
echinaforc
ef
compris
ethanol
extract
e
purpurea
aerial
part
plu
root
show
prepar
potent
virucid
agent
sever
virus
membran
indic
tabl
addit
respiratori
syncyti
viru
test
human
avian
strain
influenza
viru
well
influenza
b
viru
suscept
addit
rhinoviru
felin
caliciviru
also
equal
suscept
rel
high
concentr
ef
recommend
oral
consumpt
thu
ef
dilut
equival
mgml
dri
weightvolum
capabl
kill
least
infecti
virus
direct
contact
adenovirus
howev
resist
studi
ep
found
much
less
effect
intracellular
viru
consequ
viru
alreadi
present
within
cell
could
refractori
inhibitori
effect
ep
wherea
viru
particl
shed
extracellular
fluid
vulner
therefor
ep
act
initi
contact
viru
incept
infect
also
transmiss
viru
infect
cell
addit
experi
show
continu
passag
influenza
viru
cell
cultur
presenc
ep
result
emerg
resist
strain
wherea
passag
viru
success
cultur
presenc
tamiflu
rapidli
gener
tamiflu
resist
furthermor
tamifluresist
viru
remain
fulli
suscept
ep
therefor
continu
usag
ep
popul
would
less
like
gener
resist
strain
viru
tamiflu
antiinfluenza
compound
current
market
shown
hemagglutin
assay
ep
inhibit
receptorbind
activ
influenza
virus
rang
ep
concentr
suggest
ep
interf
viral
entri
cell
thu
effect
render
viru
noninfecti
ep
also
inhibit
neuraminidas
activ
vitro
unpublish
result
suggest
activ
compound
could
block
influenza
viru
entri
spread
act
least
two
virion
target
howev
suscept
virus
reli
ha
na
function
ep
indic
must
addit
molecular
target
rhinovirusinfect
human
bronchial
lung
epitheli
cell
use
studi
effect
ep
cellular
gene
express
secret
cytokin
chemokin
princip
mediat
inflammatori
respons
rhinovirus
stimul
secret
mani
differ
cytokin
includ
proinflammatori
known
collect
involv
mani
symptom
common
respiratori
infect
sneez
fever
sore
throat
nasal
discharg
inflamm
variou
respiratori
tissu
sever
ep
prepar
abl
complet
partli
revers
stimul
ep
could
ad
viru
infect
similar
success
also
result
affect
viru
dose
time
exposur
ep
noteworthi
known
use
distinct
cellular
receptor
ldl
resp
stimul
cytokin
secret
revers
ep
suggest
involv
multipl
signal
pathway
concept
support
demonstr
mani
transcript
factor
tf
known
associ
cytokin
chemokin
also
stimul
tf
modul
ep
treatment
virus
includ
influenza
viru
adenoviru
type
respiratori
syncyti
viru
stimul
secret
proinflammatori
cytokin
case
stimul
revers
ef
tabl
howev
live
infecti
virus
abl
infect
equival
dose
ultravioletinactiv
virus
fail
elicit
respons
suggest
viru
may
enter
cell
undergo
degre
gene
express
order
stimul
cytokin
express
secret
also
interest
virus
adenovirus
vulner
direct
attack
echinacea
could
nevertheless
stimul
cytokin
secret
still
suscept
cytokin
revers
recent
studi
influenza
ainfect
mous
macrophagelik
cell
viral
induc
product
cytokin
chemokin
also
suppress
variou
degre
ep
extract
constitu
alkylamid
detail
sever
conclus
deriv
result
probabl
import
could
correl
cytokin
inhibitori
effect
antiinflammatori
properti
specif
individu
compound
group
marker
compound
name
alkylamid
polysaccharid
caffeic
acid
deriv
case
ep
fraction
deriv
root
leav
plu
stem
flower
antiinflammatori
accord
measur
numer
viral
bacteri
infect
well
wound
result
substanti
stimul
level
proinflammatori
cytokin
especi
consequ
consid
repres
use
marker
inflammatori
condit
thu
compound
herbal
extract
inhibit
revers
elev
forth
could
consid
potenti
antiinflammatori
agent
consequ
mani
prepar
deriv
root
aerial
part
ep
would
expect
possess
antiinflammatori
properti
secret
excess
mucu
one
annoy
symptom
cold
respiratori
infect
occur
frequent
chronic
pulmonari
infect
mani
pharmaceut
design
reliev
featur
infect
usual
accompani
undesir
side
effect
mucin
product
least
mucin
gene
human
highli
glycosyl
macromolecul
constitut
part
innat
defens
system
respiratori
pathogen
chronic
condit
respons
certain
airway
infect
rhinoviru
one
gene
may
induc
hypersecret
mucin
studi
bronchial
epitheli
cell
cultur
organotyp
bronchial
tissu
cultur
rhinoviru
induc
secret
excess
domin
respiratori
mucin
ep
revers
secret
suggest
could
addit
benefit
ep
treatment
tabl
show
repres
result
import
cell
cultur
model
use
evalu
antiinfecti
agent
reflect
condit
vivo
far
possibl
condit
confirm
ep
mean
commerci
sourc
normal
human
airway
epitheli
tissu
epiairway
tissu
organotyp
model
could
propag
ex
vivo
defin
condit
tissu
architectur
differenti
pattern
preserv
accord
standard
histolog
examin
condit
effect
rhinoviru
infect
ep
variou
paramet
tissu
integr
cytokin
induct
evalu
individu
replic
tissu
sampl
maintain
insert
cultur
three
day
three
week
infect
rhinoviru
type
ep
alon
combin
two
medium
none
treatment
affect
histolog
appear
integr
tissu
maintain
high
level
cell
viabil
preserv
cilia
except
conspicu
virusinduc
mucopolysaccharid
inclus
goblet
cell
evid
viru
replic
although
rv
infect
tissu
secret
substanti
amount
proinflammatori
cytokin
respons
revers
ef
treatment
tabl
goblet
cell
also
appear
normal
free
inclus
eptreat
tissu
therefor
result
confirm
find
deriv
studi
bronchial
lung
epitheli
cell
line
name
rv
infect
result
substanti
inflammatori
respons
mucin
secret
absenc
viru
replic
gene
express
human
bronchial
cell
analyz
mean
dna
microarray
follow
treatment
one
two
ep
prepar
aqueou
extract
ethanol
extract
without
infect
rhinoviru
type
extract
influenc
express
mani
gene
includ
cytokin
gene
although
pattern
express
differ
two
extract
addit
viru
induc
numer
chang
mostli
increas
express
extract
tend
decreas
ie
restor
normal
level
express
level
analysi
effect
reveal
chang
cytokin
express
interconnect
specif
transcript
factor
cebpb
caatenhancerbind
protein
b
sinc
numer
transcript
factor
known
affect
ep
extract
cellviru
system
tempt
conclud
mani
gene
express
effect
echinacea
extract
could
due
chang
express
activ
statu
multipl
transcript
factor
turn
could
brought
interact
surfac
receptor
intracellular
modul
analys
interferon
alpha
gene
express
dna
microarray
analysi
pcr
assay
reveal
chang
cell
treat
differ
ep
extract
uninfect
bronchial
epitheli
cell
rhinovirusinfect
cell
although
certain
interferon
stimul
gene
isg
upregul
viru
downregul
ep
extract
interferon
bioassay
bronchial
cell
fail
detect
ifn
contrast
cell
stimul
known
ifn
induc
poli
c
vimalanathan
hudson
unpublish
data
neg
find
also
report
recent
mous
macrophag
cell
line
infect
author
conclud
ep
induc
littl
ifn
alpha
beta
consequ
antivir
effect
ep
like
involv
interferon
system
sever
potenti
pathogen
bacteria
capac
caus
respiratori
symptom
result
initi
interact
epitheli
cell
oral
nasal
mucosa
variou
part
lung
gener
featur
infect
organ
includ
prolifer
spread
bacteria
result
cellular
damag
often
aid
product
bacteri
virul
gene
induct
excess
proinflammatori
cytokin
lead
chronic
inflamm
herbal
medicin
bactericid
antiinflammatori
properti
could
provid
benefit
individu
suffer
respiratori
symptom
certain
prepar
ep
possess
activ
addit
antivir
activ
describ
result
summar
tabl
streptococcu
pyogen
group
streptococcu
ga
respons
widespread
infect
rang
hundr
million
rel
mild
case
pharyng
global
sever
toxic
shock
syndrom
necrot
fasciiti
flesheat
diseas
sever
symptom
ascrib
inflammatori
cytokin
cytokin
storm
addit
sever
streptococc
gene
product
virul
factor
describ
aid
bacteria
persist
oral
epithelia
saliva
dissemin
tissu
consequ
dual
action
ep
kill
bacteria
revers
proinflammatori
activ
could
signific
aid
combat
infect
hemophilu
influenza
part
normal
nasopharyng
flora
recent
addit
pathogen
strain
associ
otiti
media
chronic
bronchiti
pneumonia
initi
interact
epitheli
cell
result
proinflammatori
cytokin
secret
via
toll
receptor
mediat
ep
kill
organ
readili
also
inhibit
cytokin
induct
bronchial
epitheli
cell
tabl
legionella
pneumophila
associ
legionnair
diseas
sometim
sever
case
pneumonia
wide
distribut
water
soil
organ
inhal
aerosol
insid
alveolar
macrophag
local
rel
resist
vacuol
replic
organ
howev
sensit
ep
induct
proinflammatori
cytokin
inhibit
ep
treatment
tabl
staphylococcu
aureu
long
recogn
part
normal
skin
flora
methicillinresist
mrsa
strain
associ
recent
year
increas
frequenc
hospitalacquir
infect
result
sever
pneumonia
prepar
ep
rel
littl
effect
growth
mrsa
mssa
methicillin
sensit
aureu
effect
inhibit
proinflammatori
respons
bacteria
indic
least
partial
benefit
counteract
detriment
effect
mrsa
infect
klebsiella
pneumonia
often
associ
antibiot
resist
pneumonia
also
rel
resist
bactericid
effect
ep
mycobacterium
smegmati
sever
bacteri
opportunist
sever
conclus
drawn
result
ep
echinacea
extract
select
antibacteri
activ
ii
differ
organ
show
signific
differ
pattern
sensit
iii
correl
chemic
composit
extract
term
known
marker
compound
correspond
antibacteri
activ
iv
differ
prepar
echinacea
show
markedli
differ
effect
bacteria
indic
ep
distinct
mechan
action
bacterium
v
gener
ep
revers
stimul
proinflammatori
cytokin
regardless
induc
bacterium
viru
addit
studi
live
bacteria
sever
group
examin
effect
ep
stimul
inflammatori
mediat
bacteri
lipopolysaccharid
lp
usual
deriv
escherichia
coli
variou
human
mous
cell
cultur
see
section
model
serv
use
test
antiinflammatori
agent
although
necessarili
repres
live
bacteria
studi
togeth
indic
ep
effect
gener
antiinflammatori
agent
capabl
amelior
mani
symptom
respiratori
infect
mani
author
comment
import
coinfect
airway
respiratori
viru
bacteri
opportunist
possibl
enhanc
pulmonari
diseas
alreadi
allud
number
interest
studi
suggest
possibl
mechan
rhinovirus
respiratori
syncyti
viru
influenza
viru
alter
signal
pathway
cultur
epitheli
cell
lead
cell
membran
chang
includ
enhanc
attach
certain
bacteria
h
influenza
pneumonia
result
cytopath
effect
possibl
colon
revers
process
also
demonstr
prior
infect
epitheli
cell
h
influenza
increas
level
receptor
result
enhanc
rhinoviru
infect
sinc
ep
inactiv
virus
bacteria
contact
well
inhibit
induct
proinflammatori
cytokin
conceiv
coinfect
could
halt
ep
oral
administr
form
tinctur
spray
mani
skin
infect
caus
virus
microorgan
could
amen
topic
treatment
ep
herp
simplex
viru
type
common
infect
oral
genit
mucosa
cold
sore
genit
sore
may
becom
chronic
infect
pain
recurr
erupt
skin
kerat
infect
corneal
epithelium
stromal
tissu
may
also
recurr
major
caus
blind
fortun
infect
access
topic
agent
surprisingli
mani
antivir
drug
market
control
variabl
success
sinc
design
target
viral
gene
emerg
resist
mutant
alway
threat
howev
mani
plant
extract
evalu
antihsv
agent
shown
promis
result
sever
ep
prepar
show
potent
virucid
activ
hsv
result
alreadi
summar
section
connect
respiratori
virus
advantag
ep
broad
spectrum
activ
minim
chanc
resist
mutant
aris
high
potenc
rel
lack
cytotox
pilosebac
follicl
skin
propionibacterium
acn
domin
microb
sebac
glandular
region
inflamm
possibl
initi
bacterium
appear
two
main
instig
driver
diseas
although
factor
also
appear
involv
hormon
host
nutrit
statu
one
explan
chronic
natur
diseas
p
acn
induc
product
proinflammatori
cytokin
chemokin
well
inflammatori
mediat
attract
leukocyt
site
infect
therebi
set
cascad
inflammatori
respons
also
involv
product
reactiv
oxygen
speci
radic
combin
lead
develop
acn
lesion
convent
therapi
target
develop
lesion
mean
retino
acid
analogu
compound
antibiot
direct
bacterium
needless
say
continu
applic
antibiot
entail
risk
resist
bacteria
emerg
altern
approach
sever
recent
report
indic
possibl
use
plant
extract
counter
growth
bacteria
andor
inflammatori
respons
although
yet
evalu
vivo
eg
organ
includ
laboratori
clinic
isol
readili
inactiv
dilut
ep
well
normal
recommend
dose
topic
treatment
oral
consumpt
control
cold
flu
symptom
furthermor
bacteri
induct
proinflammatori
cytokin
evid
three
human
cell
line
examin
bronchial
epitheli
lung
epitheli
skin
fibroblast
also
inhibit
ep
suggest
extract
could
offer
dual
benefit
acn
patient
result
summar
tabl
bacterialinduc
cytokin
includ
lesser
extent
hallmark
inflammatori
respons
would
expect
lead
influx
variou
inflammatori
leukocyt
addit
secret
normal
result
attract
monocyt
combin
cytokin
could
well
explain
product
inflamm
site
infect
consequ
agent
capabl
safe
revers
effect
benefici
patient
fungi
caus
agent
numer
acut
chronic
infect
skin
mani
part
bodi
often
inaccess
immunolog
attack
limit
number
studi
report
antifung
activ
variou
echinacea
extract
includ
ep
extract
candida
speci
dermatophyt
essenti
qualit
design
mere
indic
certain
extract
could
inhibit
growth
fungi
sinc
ep
formul
oral
superfici
applic
comprehens
evalu
fungistat
fungicid
activ
could
support
valid
tradit
use
anecdot
report
success
control
chronic
fungal
infect
skin
clostridium
difficil
c
difficil
gram
posit
sporeform
gut
anaerob
associ
increasingli
recent
year
epidem
diarrhea
clostridium
difficileassoci
diarrhea
cdad
pseudomembran
coliti
especi
health
care
institut
patient
may
subject
chronic
administr
antibiot
result
disrupt
normal
balanc
gut
flora
certain
prepar
ep
capabl
kill
organ
shown
tabl
suggest
oral
consumpt
appropri
extract
possibl
tea
made
ep
could
benefici
infect
patient
report
ep
supplement
diet
appar
caus
chang
gut
bacteri
flora
clear
signific
chang
whether
benefici
trypanosoma
speci
belong
trypanosomatida
famili
leishmania
speci
mainli
transmit
bite
infect
femal
phlebotomin
sandfli
trypanosoma
speci
transmit
human
bite
infect
tsets
fli
glossina
genu
caus
sleep
sick
infect
assassin
bug
subfamili
triatomina
caus
chaga
diseas
human
parasit
caus
widespread
diseas
hundr
thousand
new
case
year
although
drug
avail
treatment
differ
stage
diseas
frequent
associ
sever
side
effect
howev
recent
studi
examin
antiparasit
properti
sever
plant
extract
promis
result
three
differ
prepar
ep
one
ethanol
extract
other
aqueou
extract
aerial
plant
part
evalu
abil
inhibit
growth
organ
vitro
antiinflammatori
activ
three
ep
prepar
exhibit
dosedepend
antileishmani
trypanocid
activ
h
incub
although
rel
potenc
vari
somewhat
extract
target
speci
gener
ethanol
extract
effect
mode
action
ep
parasit
known
may
differ
speci
bacteri
speci
section
microscop
observ
parasit
indic
ep
slow
elimin
motil
caus
cell
round
high
ep
concentr
l
donovani
also
show
proinflammatori
activ
stimul
secret
two
differ
human
cell
line
bronchial
epitheli
line
skin
fibroblast
line
similar
stimul
shown
cell
line
varieti
viral
bacteri
pathogen
describ
cell
type
select
ep
ethanol
extract
inhibit
leishmaniainduc
respons
tabl
thu
certain
echinacea
prepar
capabl
control
growth
parasit
inhibit
inflammatori
activ
induc
mani
plant
extract
shown
contain
antioxid
properti
accord
sever
standard
test
phenol
compon
often
incrimin
addit
gener
accept
nutrit
health
benefit
ad
antioxid
diet
variou
acut
chronic
infect
associ
neg
effect
intracellular
redox
balanc
includ
decreas
reduc
glutathion
import
cellular
antioxid
could
advers
effect
cellular
metabol
sever
report
demonstr
antioxid
properti
ep
prepar
therefor
supplement
ep
infect
could
provid
addit
host
protect
restor
normal
redox
statu
sever
studi
report
effect
echinacea
prepar
cellular
gene
express
uninfect
human
cell
relev
immun
system
chang
nk
cell
cell
surfac
antigen
describ
blood
cell
taken
human
treat
ep
randolph
et
al
describ
chang
level
express
term
mrna
protein
sever
cytokin
gene
human
blood
sampl
taken
differ
time
treatment
commerci
echinacea
product
brovelli
et
al
found
express
sever
cytokin
gene
cultur
human
monocyt
influenc
natur
echinacea
prepar
stage
develop
plant
part
use
presum
reflect
differ
chemic
composit
wang
et
al
describ
effect
butanol
fraction
deriv
aerial
part
e
purpurea
gene
express
immunerel
molecul
human
dendrit
cell
part
adapt
immun
respons
mani
dendrit
cell
gene
affect
either
upregul
downregul
modul
sever
cytokin
ep
extract
also
report
cultur
mous
dendrit
cell
none
studi
includ
infect
cell
clearli
confirm
ep
produc
multipl
gene
effect
immun
cell
mani
group
last
year
investig
effect
echinacea
prepar
immun
function
cell
cultur
mous
origin
gener
incub
periton
alveolar
spleen
monocytemacrophagelymphocyt
prepar
ep
result
stimul
phagocytosi
cytokin
secret
review
contrast
studi
describ
infect
airway
epitheli
cell
fibroblast
ep
gener
act
antiinflammatori
agent
via
numer
chang
gene
express
studi
partial
purifi
ep
polysaccharid
deriv
vitro
ep
plant
cultur
stimul
phagocyt
activ
macrophag
also
observ
wherea
isol
echinacea
alkylamid
individu
group
invari
display
immun
suppress
variou
cultur
cell
unfortun
earlier
studi
gave
rise
popular
belief
echinacea
act
gener
immun
stimul
immun
booster
statement
persist
today
mani
commerci
label
web
site
descript
recent
studi
howev
refer
appropri
immun
modul
rather
gener
immun
stimul
eg
thu
net
result
interact
ep
cell
vivo
like
influenc
composit
extract
natur
locat
cell
type
rining
et
al
made
differ
seri
observ
report
sever
prepar
ep
show
minim
effect
product
cytokin
mous
cultur
unless
extract
first
expos
simul
gastric
intestin
digest
protocol
whereupon
acquir
abil
stimul
cytokin
secret
result
clearli
relev
normal
consumpt
echinacea
remain
unexplain
mous
macrophag
cell
line
raw
respond
lp
bacteri
lipopolysaccharid
treatment
stimul
product
inflammatori
mediat
nitric
oxid
ep
abl
inhibit
effect
accord
anticytokin
effect
describ
preliminari
studi
sharma
hudson
unpublish
result
rhinoviru
also
stimul
product
cell
ep
revers
effect
thu
although
potenti
phagocyt
cell
stimul
ep
similar
cell
alreadi
stimul
lp
possibl
live
bacteria
inhibit
ep
indic
tendenc
ep
restor
normal
immun
function
eptreat
rat
assess
spleen
lung
macrophagerel
function
includ
phagocyt
activ
cytokin
stimul
stimul
treat
anim
agreement
studi
mous
cell
cultur
vitro
studi
ep
polysaccharid
deriv
plant
cultur
treat
normal
immunosuppress
mice
could
protect
lethal
dose
either
listeria
monocytogen
candida
albican
appar
result
reduc
titer
organ
target
tissu
similar
benefici
effect
standard
ep
extract
also
observ
recent
studi
mice
infect
listeria
monocytogen
whether
protect
case
due
enhanc
phagocyt
activ
clearanc
organ
variou
tissu
direct
contact
ep
compon
organ
combin
factor
clear
studi
recent
report
describ
success
use
polysaccharideenrich
aerial
ep
extract
control
cours
influenza
viru
infect
well
character
strain
mice
appar
effect
lung
viru
titer
signific
effect
variou
cytokin
level
lung
sera
author
conclud
benefit
ep
treatment
result
modul
inflammatori
cytokin
rather
direct
antivir
activ
concur
studi
indic
antiinflammatori
properti
ep
thu
ep
could
still
benefici
system
infect
ep
compon
unlik
make
direct
contact
viru
miller
colleagu
made
sever
studi
effect
dietari
ep
extract
age
surviv
mice
sever
paramet
growth
indic
possibl
benefit
ep
diet
noteworthi
posit
effect
lifelong
stimul
nk
cell
activ
function
could
theoret
help
anim
deal
infecti
diseas
domest
anim
includ
pet
livestock
fish
requir
treatment
point
live
viral
microbi
diseas
caus
organ
usual
analog
correspond
human
counterpart
alreadi
discuss
exampl
avian
influenza
virus
anim
herp
virus
variou
respiratori
virus
bacteria
mani
fungal
parasit
infect
consequ
respons
echinacea
treatment
either
direct
antivir
antimicrobi
antiinflammatori
agent
addit
organ
especi
bacteria
salmonella
campylobact
speci
also
import
sourc
contamin
food
furthermor
comment
point
need
evalu
herbal
prepar
replac
least
part
antibiot
onslaught
farm
anim
often
receiv
certain
herb
includ
echinacea
modern
tradit
veterinari
applic
north
america
europ
although
rel
report
describ
basic
studi
analog
describ
human
diseas
even
control
trial
anim
invari
treatment
conclud
safe
free
signific
side
effect
conclus
also
support
studi
mice
rat
describ
previou
section
toxic
effect
observ
regard
infect
studi
chick
infect
protozoan
parasit
coccidia
conclud
dietari
supplement
ep
root
extract
significantli
decreas
lesion
score
improv
health
anim
comparison
anim
rais
normal
diet
although
immun
paramet
measur
consequ
clear
effect
ep
direct
parasit
immun
system
nevertheless
effect
treatment
coccidiosi
would
welcom
poultri
industri
hand
studi
young
pig
dietari
ep
found
offer
protect
porcin
reproduct
respiratori
syndrom
viru
prr
viru
sinc
viru
member
arteriviru
famili
relat
coronavirus
possess
membran
would
expect
suscept
direct
contact
ep
howev
system
natur
infect
could
render
inaccess
dietari
echinacea
compon
altern
treatment
protocol
might
inadequ
addit
control
infect
domest
anim
herbal
prepar
advoc
thing
immun
stimul
growth
promot
perform
enhanc
studi
carri
uninfect
hors
fish
tilapia
suggest
possibl
echinacea
prepar
safeti
consid
problem
anim
fish
like
farm
anim
alway
potenti
vulner
viral
microbi
infect
especi
condit
stress
consequ
altern
treatment
synthet
antimicrobi
could
use
case
need
remind
unpredict
natur
microbi
epidemiolog
sar
epidem
erupt
china
late
quickli
spread
mani
countri
next
year
half
result
serious
infect
individu
nearli
die
epidem
offici
record
first
pandem
centuri
result
emerg
global
public
health
measur
diseas
halt
appear
control
although
continu
vigil
necessari
case
caus
viru
return
novel
coronaviru
respons
sar
cov
believ
anim
origin
isol
genom
quickli
sequenc
howev
satisfactori
antivir
therapi
avail
studi
autopsi
lung
tissu
reveal
viral
nucleoprotein
rna
present
mainli
alveolar
epitheli
cell
probabl
initi
site
viru
replic
lesser
extent
macrophag
could
mode
system
transmiss
recent
review
summar
studi
sar
cov
infect
cell
cultur
emphas
role
innat
immun
respons
viru
infect
viru
like
coronavirus
respiratori
virus
stimul
inflammatori
cytokin
secret
although
coronavirus
gener
induc
antivir
interferon
thu
modul
cytokin
evas
innat
immun
defenc
could
import
contributor
sar
viru
patholog
therefor
herbal
prepar
like
ep
antiinflammatori
virucid
properti
could
use
sar
return
need
standard
ep
alreadi
stress
paper
studi
reinforc
concept
variat
among
differ
prepar
differ
supplier
common
problem
herb
sinc
exact
chemic
composit
vari
differ
part
plant
age
season
harvest
exact
method
extract
hand
found
studi
standard
prepar
ep
retain
full
antivir
activ
sever
year
provid
storag
condit
appropri
unpublish
result
similarli
prepar
ep
maintain
cytokinestimul
activ
storag
two
year
presenc
multipl
antivir
activ
among
differ
extract
fraction
suggest
mani
kind
echinacea
prepar
tinctur
spray
tablet
tea
forth
could
benefici
treatment
infect
although
prepar
like
effect
recent
studi
commerci
prepar
highlight
variabl
antivir
activ
differ
prepar
although
lottolot
variat
less
evid
gener
ethanolbas
extract
greater
antivir
activ
aqueou
extract
possibl
identifi
specif
compon
respons
activ
furthermor
correl
antivir
antiinflammatori
activ
commerci
prepar
echinacea
includ
ep
compris
mixtur
ep
nonechinacea
herb
rational
two
herb
better
one
three
even
better
etc
respect
mixtur
may
consid
analog
complex
mixtur
often
advoc
chines
tradit
medicin
tcm
ayurved
medicin
howev
basic
assumpt
necessarili
valid
preliminari
studi
examin
number
mixtur
ep
standard
herb
antivir
activ
major
case
mixtur
much
less
effect
ep
none
better
ep
unpublish
data
howev
sinc
know
exact
mechan
ep
antivir
activ
natur
activ
compound
explain
phenomena
lesson
obviou
name
ep
prepar
potent
antivir
agent
mix
unknown
echinacea
extract
intend
treatment
cold
flu
sore
throat
normal
market
oral
consumpt
activ
ingredi
therefor
acquir
immedi
exposur
mucos
epithelia
accord
studi
standard
prepar
describ
recommend
applic
ensur
physiolog
relev
amount
say
adequ
local
antivir
antibacteri
antiinflammatori
concentr
achiev
normal
condit
consumpt
subsequ
absorpt
metabol
variou
compon
howev
less
relev
applic
sinc
site
infect
inflamm
level
airway
epitheli
tissu
nevertheless
demonstr
alkylamid
possibl
addit
compon
absorb
quickli
blood
remain
circul
time
least
follow
e
angustifolia
administr
although
ep
extract
tend
rel
alkylamid
therefor
depend
exact
chemic
composit
echinacea
extract
could
benefit
consum
addit
initi
interact
oral
mucosa
numer
studi
carri
human
object
prevent
treat
common
cold
critic
summar
unfortun
use
inadequ
character
echinacea
prepar
deriv
variou
extract
protocol
differ
speci
plant
part
like
chemic
composit
extract
consequ
bioactiv
differ
substanti
attempt
ration
interpret
result
use
metaanalys
encount
problem
name
result
variabl
test
materi
consequ
surpris
issu
controversi
mani
popular
scientist
pseudoscientist
jump
conclus
efficaci
lack
efficaci
echinacea
prevent
treat
common
cold
spite
reserv
overal
trend
toward
benefici
effect
echinacea
equal
importantli
safeti
prepar
confirm
repeatedli
includ
trial
children
comprehens
trial
also
includ
influenza
viru
respiratori
virus
incorpor
use
wellcharacter
bioactiv
echinacea
extract
need
confirm
benefit
oral
echinacea
use
done
left
overwhelm
anecdot
experi
addit
encourag
result
cell
tissu
cultur
studi
anim
studi
definit
conclus
regard
clinic
efficaci
human
result
describ
indic
echinacea
extract
evid
contain
compound
combin
compound
abil
interact
specif
viral
microbi
target
addit
extract
affect
variou
signal
pathway
epitheli
cell
inhibit
virusbacteriuminduc
secret
cytokineschemokin
inflammatori
mediat
respons
pulmonari
symptom
sinc
mani
signal
pathway
affect
echinacea
differ
cell
type
includ
immun
cell
conceiv
overal
benefici
effect
due
particular
combin
compound
act
synergist
exampl
synerg
herbal
medicin
describ
case
valid
experiment
like
certain
echinacea
prepar
also
display
synerg
howev
spite
attempt
correl
bioactiv
echinacea
prepar
recogn
chemic
marker
polysaccharid
caffeic
acid
deriv
alkylamid
succeed
contrast
preliminari
evid
laboratori
implic
class
compound
unpublish
data
studi
ep
indic
multipl
action
herbal
prepar
result
either
individu
activ
sever
compound
synergist
effect
differ
compound
result
benefit
direct
virucid
activityact
sever
virus
involv
respiratori
infect
concentr
cytotox
direct
bactericid
action
certain
potenti
pathogen
respiratori
bacteria
inactiv
microbi
pathogen
relev
human
domest
anim
revers
proinflammatori
respons
epitheli
cell
tissu
variou
virus
bacteria
modul
certain
immun
cell
function
revers
excess
mucin
secret
induc
rhinoviru
bioactiv
result
chang
gene
express
thu
combin
benefici
activ
could
reduc
amount
prevail
viabl
pathogen
transmiss
also
lead
amelior
symptom
infect
